Dabrafenib plus trametinib vs encorafenib plus binimetinib in BRAF-mutant metastatic melanoma: a real-world propensity score–matched survival analysis
- Journal:
- Journal of the National Cancer Institute
- Published:
- DOI:
- 10.1093/jnci/djaf263
- Affiliations:
- 4
- Authors:
- 13
| Institutions | Authors | Share |
|---|---|---|
| National Center for Cancer Immune Therapy (CCITdk), Denmark | 0.46 | |
| Aarhus University Hospital, Denmark | 0.23 | |
| Odense University Hospital (OUH), Denmark | 0.23 | |
| Aalborg University Hospital, Denmark | 0.08 |